BioRegenx, Inc. Announces the Resignation of Jody M. Walker as Director
July 15, 2024 at 09:37 pm IST
Share
BioRegenx, Inc. announced that in conjunction with her retirement, Jody M. Walker resigned as a director of the Company effective as of July 13, 2024. Her departure was not a result of any disagreement with the Company, its Board or management.
BioRegenx, Inc., formerly Findit, Inc., operates as a holding company. The Company specializes in acquiring intellectual property (IP) and companies engaged in regenerative biotherapeutics and anti-aging research. Its primary focus involves acquiring and developing non-invasive medical and wellness devices capable of efficiently recording, storing, and analyzing datasets. The Companyâs patented technologies and solutions include GlycoCheck, a high-definition video imaging that analyzes five parameters of microvascular health non-invasively with an under the tongue test using patented technology; Endocalyx Pro, an all-natural, plant-based patented nutraceutical shown to restore, regenerate, and protect microvascular health. Clinically tested in multiple double-blind placebo studies, and DocSun, an artificial intelligence using three advanced facial recognition technologies that analyzes 21 vital signs and health indicators without physical contact.
BIOREGENX, INC. 
